{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21054 MSE Policy for Management of Antimicrobials 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "DOCUMENT TITLE:"
                    },
                    {
                        "text": "POLICY FOR MANAGEMENT OF ANTIMICROBIALS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21054"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the prescribing, dispensing and administering of antimicrobials"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "20 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "19 April 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Antimicrobial Management, antibiotics, AMS"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NICE guideline (NG15) August 2015. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use."
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 9 - Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Principal Pharmacist- MSE Antimicrobial Stewardship Lead"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Medicines Assurance Group (MAG) Chair Action E.Allen in lieu of meeting."
                    },
                    {
                        "text": "16 April 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "16 April 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "20 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "May 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 3
        },
        {
            "type": "image",
            "sequence_num": 4,
            "data": {
                "url": "MSEPO-21054 MSE Policy for Management of Antimicrobials 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 10,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Pharmacy Head of Department (Southend)"
                    },
                    {
                        "text": "22 March 2021"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Principal Pharmacist Medication Safety"
                    },
                    {
                        "text": "23 March 2021"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Pharmacy Head of Department (Broomfield)"
                    },
                    {
                        "text": "29 March 2021"
                    },
                    {
                        "text": "John Day"
                    },
                    {
                        "text": "Infectious Disease consultant (Southend)"
                    },
                    {
                        "text": "29 March 2021"
                    },
                    {
                        "text": "Javeed Ahmed"
                    },
                    {
                        "text": "Lead Microbiology Consultant (MSE)"
                    },
                    {
                        "text": "29 March 2021"
                    },
                    {
                        "text": "Abiodun Ogundana"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist (Basildon)"
                    },
                    {
                        "text": "31 March 2021"
                    },
                    {
                        "text": "Hayley Reeves"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist (Southend)"
                    },
                    {
                        "text": "03 April 2021"
                    },
                    {
                        "text": "Chiamaka Oduoza"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist (Broomfield)"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "Paul Smith"
                    },
                    {
                        "text": "Pharmacy Clinical Lead (Southend)"
                    },
                    {
                        "text": "29 March 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Antimicrobial stewardship group (Southend)"
                    },
                    {
                        "text": "29 March 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Infection Prevention & Control Strategy, or equivalent Policy for the Safe Handling of Medicines, or equivalent Policy for the Administration of Medicines, or equivalent MSEPO-20206 Policy for the Management of and Learning from Medication Error Incidents MSBPO-18020 RM Policy for the Management of Allergy Status MSEPO-19014 Policy for Management of Incidents All Antimicrobial Medicines Management Guidelines on all sites"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 8,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Rev iewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Harmonised for MSE. Replaces Southend MMP038. New document for Broomfield and Basildon."
                    },
                    {
                        "text": "20 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Roles and Responsibilities ............................................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Site Antimicrobial Stewardship Core Group ................................................................ 11"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Antimicrobial Prescribing Guidelines .......................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Quality Assurance / Audits .......................................................................................... 13"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Education & Training .................................................................................................. 14"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Monitoring and Audit ................................................................................................... 14  Approval and Implementation ..................................................................................... 15  Equality Impact Assessment ....................................................................................... 15  References ................................................................................................................. 16"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 1 - Components of Best Practice for Antibiotic Prescribing (Treatment) ............ 17"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Appendix  - Components of Best Practice for Antibiotic Prescribing (Peri-operative prophylaxis) ....................................................................................................................... 19"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 3: Preliminary Equality Analysis ......................................................................... 21"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 40.0,
                "text": "Antimicrobial resistance (AMR) has risen alarmingly over the lastyears, there has been a 32% increase in the estimated number of antibiotic resistant bloodstream infections from key bacterial species between 2015 and 2019; overprescribing, prolonged and inappropriate use of antimicrobials are the main drivers. Antibiotic consumption in England has been falling since the peak in 2014, but the use in hospitals (by hospital admissions) has increased by 3.5% over the last 5years."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The consequences of AMR which include treatment failure, and limited antimicrobial choices have led to the issue of Patient Safety Alert (August 2015), by both NHS England and Public Health England (PHE)."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "This alert aims to highlight the importance of antimicrobial stewardship through the development of Start Smart-Then Focus antimicrobial stewardship toolkit."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Significant concerns regarding overprescribing have also led to the development of AMR CQUIN in April 2016, and nationwide Antibiotic Guardian (AG) campaign. AG campaign website was visited 82,992 times in 2019, which resulted in 9,289 pledges."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "The Health & Social Care Act of 2008 formalised the need for improved governance around the use of antimicrobials to help reduce the incidence of healthcare associated infections such as Clostridium difficile and Methicillin Resistant Staphylococcal Aureus (MRSA)."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.6,
                "text": "This policy is designed to be used by all staff who are involved in the prescribing, administration, supply or monitoring of antimicrobials. It is intended to help ensure the safe and appropriate use of these medicines through provision of a written framework that covers strategic and practical policy statements, supported by an effective audit programme."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2040.0,
                "text": "Ensure Department of Health and Social Care national best practice for the use of antimicrobials is adhered within the Trust. This includes implementation of UK five year antimicrobial resistance action plan 2019-2024, and  year vision to contain and control AMR by"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The scope of this policy relates to any patient of any age treated with antimicrobials by the Trust."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "type": "table",
            "sequence_num": 34,
            "data": {
                "num_rows": 22,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Anthelmintic"
                    },
                    {
                        "text": "Medication capable of causing the evacuation of parasitic intestinal worms."
                    },
                    {
                        "text": "Antimicrobial"
                    },
                    {
                        "text": "A therapeutic agent (typically a medicine) used to kill or reduce the number of microbes. This will include Antibacterials, Antivirals, Antifungals, Antiprotozoals (& Anthelmintic) i.e. any therapeutic agent in BNF Chapter 5. On a daily basis, antibacterials provide the main group."
                    },
                    {
                        "text": "Antimicrobial Stewardship"
                    },
                    {
                        "text": "Co-ordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration."
                    },
                    {
                        "text": "Antiprotozoal"
                    },
                    {
                        "text": "Medication capable of treating infections caused by protozoa (amoebae, flagellates, ciliates and sporozoa)."
                    },
                    {
                        "text": "AMR"
                    },
                    {
                        "text": "Antimicrobial resistance."
                    },
                    {
                        "text": "AMS"
                    },
                    {
                        "text": "Antimicrobial stewardship."
                    },
                    {
                        "text": "CQUIN"
                    },
                    {
                        "text": "\u2018Commissioning for Quality and Innovation' This system was introduced in 2009 to make a proportion of healthcare providers' income conditional on demonstrating improvements in quality and innovation in specified areas of patient care. The CQUIN scheme is intended to deliver clinical quality improvements and drive transformational change. For the purpose of this policy, this relates to antimicrobial targets and indicators within the current CQUIN scheme that apply to the Trust."
                    },
                    {
                        "text": "Daily defined doses (DDD)"
                    },
                    {
                        "text": "The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults."
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director of Infection Prevention & Control."
                    },
                    {
                        "text": "IPCG"
                    },
                    {
                        "text": "Infection Prevention & Control Group (or equivalent)"
                    },
                    {
                        "text": "DHSC (Formerly DoH)"
                    },
                    {
                        "text": "Department for Health and Social Care (Formerly Department of Health)."
                    },
                    {
                        "text": "PHE"
                    },
                    {
                        "text": "Public Health England."
                    },
                    {
                        "text": "ESBL"
                    },
                    {
                        "text": "Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes that can be produced by bacteria making them resistant to most antibacterials, especially the penicillins and the cephalosporins. They are often found in urinary tract infections."
                    },
                    {
                        "text": "MC&S"
                    },
                    {
                        "text": "Microscopy, culture and sensitivity testing"
                    },
                    {
                        "text": "Microbe"
                    },
                    {
                        "text": "Microbes are living organisms that multiply frequently and spread rapidly. They include bacteria (e.g., Staphylococcus aureus, which causes some staph infections), viruses (e.g., influenza, which causes the flu), fungi (e.g., Candida albicans, which causes some yeast infections), and parasites (e.g., Plasmodium falciparum, which causes malaria). Some microbes cause disease, and others exist in the body without causing harm and may actually be beneficial."
                    },
                    {
                        "text": "MRSA"
                    },
                    {
                        "text": "Methicillin Resistant Staphylococcal Aureus."
                    },
                    {
                        "text": "OPAT"
                    },
                    {
                        "text": "Outpatient Parenteral Antibiotic Therapy."
                    },
                    {
                        "text": "Restricted"
                    },
                    {
                        "text": "Antimicrobials that are on the Trust formulary but require"
                    },
                    {
                        "text": "Antimicrobials"
                    },
                    {
                        "text": "microbiologist or antimicrobial pharmacist authorisation before pharmacy may supply."
                    },
                    {
                        "text": "Retrospective Antibiotic Consumption data"
                    },
                    {
                        "text": "Information collected from already treated patients relating to the use of antibiotics in terms of DDD."
                    },
                    {
                        "text": "TDM"
                    },
                    {
                        "text": "Therapeutic Drug Monitoring is the assessment of treatment effectiveness through the collection and analysis of drug blood levels. This is undertaken for drugs where the toxic and therapeutic levels are close e.g. Gentamicin."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Patient Safety & Quality Group"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by the Site Medicines Optimisation and Safety Groups (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring addition of any new antimicrobials onto the formulary is controlled and formally approved (and removal from the formulary of any antimicrobials no longer Trust approved);"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Nurse or Site Director of Nursing or Medical Director as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Patient Safety & Quality Group on developments, concerns and progress concerning antimicrobial use."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Site Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting antimicrobial incidents to the site Antimicrobial Stewardship Group, as requested;"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to site divisional governance groups and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Site Infection Prevention and Control Committee (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving quarterly AMS reports and taking action as necessary."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Site Antimicrobial Stewardship (AMS) Group (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting directly to the site Director of Infection Prevention & Control;"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertaking an annual review of evidence based local antimicrobial policies (including treatment of common infections, therapeutic drug monitoring guidance and surgical prophylaxis);"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertaking a biennial review of guidelines that relate to the management of infections with antimicrobials;"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring AMR CQUIN is implemented within the Trust;"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure antimicrobial prescribing audits are carried out at least once every quarter, and actions to address non-adherence to the guidelines are identified."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing an annual report to IPC to include CQUIN performance, AMS activities, and an assessment against the Acute Hospital Antimicrobial Stewardship Tool (NICE 2015) with any resulting action plan;"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Engage in horizon scanning of new antimicrobials, monitor and evaluate the suitability of formulary requests for new antimicrobials in the Trust; Reviewing the restricted antimicrobials list annually;"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the implementation and review of the antimicrobial training strategy;"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring regular auditing of the guidelines, antimicrobial stewardship practice and quality assurance measures (i.e. the content of this policy);"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identifying actions to address non-adherence with local guidelines & general antimicrobial stewardship issues;"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Formally reporting a regular review of the organisation's retrospective antibiotic consumption data (including broad spectrum antibiotic use e.g. cephalosporins, quinolones and carbapenems);"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure prescribers have access to timely microbiology diagnosis, susceptibility testing and reporting of results, preferably within 24-72hours;"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure all antimicrobial prescribers receive induction and training on prudent antimicrobial use."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Chief Medical Officer"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring there is policy compliance through liaising with the Site Medical Directors;"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated antimicrobial issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Site Medical Directors"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee;"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated antimicrobial issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Divisional Medical/Clinical Directors"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring prescribers are implementing and monitoring antimicrobial management in their areas;"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring areas under their responsibility are appropriately monitored and supported following audit to ensure sustained improvement is achieved."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Chief Nursing Officer"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Site Pharmacy, Head of Department & MSE Lead Antimicrobial Pharmacist that antimicrobial stewardship activities are run effectively;"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated antimicrobial issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Site Director of Nursing"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated antimicrobial issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring production of appropriate reports to the Trust Board."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Site Director of Infection Prevention & Control (DIPC)"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring antimicrobial stewardship is effectively implemented within the Trust;"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the Infection & Prevention Control Committee effectively manage any concerns raised relating to the use of antimicrobials;"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing the trust board with an annual report regarding Antimicrobial Stewardship;"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring antimicrobial guidelines are informed by local microbiological sensitivity patterns;"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the microbiology laboratory selectively report sensitivities in line with current local guidelines / formulary choices;"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring multidisciplinary antimicrobial ward rounds occur at least weekly;"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring advice for prescribers is available from consultant microbiologists 24/7;"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any repeated cases of non-adherence to policy / guidelines are"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "considered for formal investigation (especially where adverse patient outcomes have occurred);"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring antimicrobial audit programme is undertaken and reviewed annually."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for antimicrobials across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standard."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Pharmacist delegates this responsibility to the site pharmacy heads of department and site clinical lead pharmacists for delivery."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.14,
                "text": "Site Pharmacy Head of Department"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring there is sufficient antimicrobial pharmacist support at the site that is dedicated for AMS activities. This responsibility may be delegated to the site clinical lead pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.15,
                "text": "Site Clinical Lead Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the site lead antimicrobial pharmacist is able to spend majority of their time on antimicrobial related activities (minimum 0.6wte);"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the antimicrobial pharmacist is supported in continuing education of infection management;"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any requests for increased pharmacist presence on wards / ward rounds to support improving adherence to antimicrobials are formally acknowledged and actions communicated to the MSE lead antimicrobial pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.16,
                "text": "MSE Principal Pharmacist- MSE Antimicrobial Stewardship Lead"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Manage and develop the roles of all antimicrobial pharmacists across the MSE Trust to meet the needs of the present and future AMS activities, and promote prudent antimicrobial prescribing without compromising patient's safety;"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Develop, facilitate and implement an antimicrobial stewardship strategy for MSE Trust in conjunction with the site antimicrobial pharmacist leads, antimicrobial stewardship groups, heads of pharmacy department and the CCG;"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitate, implement and strategize action plan to achieve any antimicrobial related Public Health England (PHE) initiated CQUIN, and key performance indicators (KPIs) targets across the MSE hospitals;"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Submit quarterly CQUIN and KPI reports to the relevant governmental bodies;"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Develop yearly AMS plan for the site lead antimicrobial pharmacists and monitor execution of the plan;"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure prescribing and dispensing of antimicrobials is undertaken to reflect MSE and CCG antimicrobial formulary and to participate in the regular review of drugs used to treat infections; following local, regional and national recommendations;"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Collate antimicrobial stewardship activity reports across the hospitals and submit to both MSE IPC and MAG quarterly;"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure document control exists for all antimicrobial guidelines;"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure only current antimicrobial guidelines are available electronically via the intranet;"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Act as a non-medical prescriber within own competences and role;"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide specialist information and advice within remit, on all aspects of antimicrobials for treating infections to doctors, nurses, other healthcare professionals within MSE Trust and areas supplied under service level agreements;"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Actively participate in clinical management team meetings, as needed, to report on AMS activities and clinical governance issues concerning antimicrobial use in MSE Trust."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.17,
                "text": "Site Antimicrobial Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Act as the site lead for facilitating antimicrobial stewardship activities;"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring antimicrobial guidelines provide guidance on prescribing in line with NICE recommendations;"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring IV to Oral Switch Guidelines are current, published and enforced;"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring cost effective prescribing of antimicrobials, and provide specialist information and advice for medical, nursing and pharmacy staff at site;"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring execution of action plan to achieve CQUIN, KPIs and audit targets"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they attend antimicrobial ward rounds regularly, and providing expert prescribing advice and contributing to MDT;"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring implementation of the audit programme based on PHE antimicrobial prescribing principle of \u2018 Start Smart, then Focus';"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring each clinical division and directorate within, is audited as scheduled and provided with feedback on performance;"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they monitor and report antibiotic consumption (using Daily Defined Doses) including AMS activity report to site IPCC, AMS group and MSE lead antimicrobial pharmacist on a quarterly basis;"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Investigating all omitted / delayed (> 1hour) first doses of antimicrobials and"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "reporting to the AMS Group;"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Proactive in risk management, ensuring all antimicrobial-related clinical incidents are reported and appropriate action is taken in conjunction with the site MOSG and clinical lead;"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing a quarterly feedback to clinical divisions, and directorates within, and action plans agreed (with updates at subsequent meetings);"
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing a quarterly CQUIN and KPI reports to the site AMS group and the MSE Principal Antimicrobial Pharmacist;"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating education and training of doctors, Pharmacy staff and nurses within their sites, on relevant aspects of AMS and AMR."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.18,
                "text": "Prescribers"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring allergy status is completed prior to prescribing;"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring cases are assessed for previous antimicrobial therapy and previous infections with multi-resistant organisms before prescribing;"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring nil by mouth status is regularly assessed and documented to facilitate oral administration of antimicrobials where clinically indicated;"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all first doses of IV antimicrobials are prescribed as stat doses (including required time of administration) and communicating directly with the nurse/midwife looking after that patient, at that time;"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting with achieving current elements of CQUIN (see monitoring compliance section) and Trust KPIs;"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Incident reporting any policy breaches in accordance with Trust policies MSEPO- 19014 and MSEPO-20206;"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adhering to antimicrobial policies and guidelines including the Department of Health \u2018Start Smart then Focus' principle of antimicrobial prescribing."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.19,
                "text": "Registered Nursing staff"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting with adherence to antimicrobial policies and guidelines on wards;"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting in ensuring every antimicrobial prescription has a stop or review date;"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring allergy status is completed prior to administering;"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring nil by mouth status is regularly assessed and documented to facilitate oral administration of antimicrobials where clinically indicated;"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring injectable antimicrobials are appropriately prioritised on the drug administration round to ensure minimal delay to administration;"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure the medicine omitted code for \u2018not available' is never used for any first dose antimicrobial and not more than once for any subsequent doses. They must ensure appropriate action is always taken to ensure a dose is obtained as soon as possible in accordance with the Trust Administration of Medicines Policy, or equivalent;"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Incident reporting any policy breaches in accordance with Trust policies MSEPO- 19014 and MSEPO-20206."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Registered Pharmacist and Pharmacy Technician"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Champion AMS within their clinical areas;"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting with antimicrobial audits;"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting with adherence to antimicrobial policies and guidelines on wards and through education / training;"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring allergy status is completed prior to dispensing (with minimal delay)"
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all wards have clear information on current antimicrobial stock lists, where to check the list, how to order antimicrobials, and how to acquire non-stock and stock antimicrobials in a timely fashion;"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any requests for antimicrobials are appropriately managed to avoid any missed doses or delays (especially first doses);"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Highlighting non formulary requests or non-approved use of restricted antimicrobial use to the site Antimicrobial Pharmacist (or Consultant Microbiologist in their absence);"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Incident reporting any policy breaches in accordance with Trust policies MSEPO-19014 and MSEPO-20206."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Site Antimicrobial Stewardship Core Group"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "To ensure a multidisciplinary approach, improve engagement across the organisation and based on NICE recommendations this group must contain as a minimum:"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consultant clinical microbiologist or infectious diseases specialist;"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Antimicrobial pharmacist/infectious diseases pharmacist;"
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A physician;"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A surgeon;"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A senior member of the pharmacy management team;"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A senior nurse."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "A ward-focused antimicrobial team must function in addition to the stewardship group. This team containing the antimicrobial pharmacist and consultant microbiologist/infectious diseases specialist reports to Antimicrobial Stewardship Group and are responsible for reviewing prescriptions at ward level on multi- disciplinary antimicrobial stewardship ward rounds."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Antimicrobial Prescribing Guidelines"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The Antimicrobial Stewardship Group is responsible for all antimicrobial guidelines within the Trust. Whilst each specialty must be consulted on any developments or indeed develop local guidelines for their own infections, they must be approved by this group prior to ratification by the Medicines Assurance Group (MAG)."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Guidelines must be evidence-based, relevant to the local healthcare setting and take into account local antibiotic resistance patterns. They should cover treatment of common infections, TDM, surgical prophylaxis and prophylaxis of infection."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Responsibility for guideline implementation resides with the Antimicrobial Stewardship Group."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Goals and essential elements of Antimicrobial prescribing:"
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure adherence to the principle of antimicrobial prescribing: \u2018Start Smart, then Focus':"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Start Smart is:"
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Then Focus is:"
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "*Change includes de-escalation of therapy i.e. to a narrower spectrum agent based on any new clinical information e.g. sensitivities"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Minimise unnecessary prescribing of antimicrobials by providing clear clinical case definitions and associated evidence of infection;"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Emphasise the need for standard infection prevention and control precautions where appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For severe or life-threatening infection, emphasise the urgent need to start treatment with broad-spectrum antibiotic agents (particularly where the source of infection is uncertain);"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For less severe infection, offer antibiotic agent(s) with an adequate spectrum to cover only the expected pathogens. Broad-spectrum antibiotics are sometimes not as potent in vitro as their narrower-spectrum counterparts against certain pathogens;"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Remind prescribers to consider the risk of resistant pathogens such as MRSA or ESBL-producing organisms and offer alternative treatment regimens accordingly or encourage prescribers to seek expert advice;"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Highlight the importance of confirming allergy status and offer alternative treatment choices for patients intolerant of recommended antibiotic agents;"
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Require prescribers to take appropriate specimens for microscopy, culture and sensitivity testing (MC&S) before starting antibiotic treatment wherever possible but not to delay starting treatment in patients who are severely ill;"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Recommend intravenous administration only to patients who are severely ill, unable to tolerate oral treatment, or where oral therapy would not provide"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "adequate coverage or tissue penetration;"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Recommend antibiotic doses and remind prescribers to adjust dosing in renal or hepatic impairment;"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Require prescribers to review microbiology results daily, and offer empirical de- escalation antibiotic choices;"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Offer oral switch choices for intravenous antibiotics;"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide advice regarding monitoring and follow-up and contingency advice for treatment failure;"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Suggest typical treatment course length for intravenous and oral agents;"
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Require single dose surgical prophylaxis regimens as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients or their advocate (if the patient lacks capacity as assessed under the Mental Capacity Act 2005) must be informed when they have been prescribed an antimicrobial and the rationale. They must also be informed of the risks and side- effects of the antimicrobial treatment;"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients discharged on antimicrobials must be informed (or their advocate) of this intention and the reasons. The explanation must also include the course duration, the importance of finishing the course, and possible risks and side- effects (including what to do if they develop when home)."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Quality Assurance / Audits"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "There is an ongoing programme of audit, revision and update monitored by the Antimicrobial Stewardship Group under the supervision of the DIPC. This is to ensure prudent antibiotic prescribing and antimicrobial stewardship. These audits are led by the MSE or site Antimicrobial Pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Regular (at least annual) feedback of adherence to prescribing standards must be provided to the Trust Board, prescribers, lead clinicians and microbiologists, nurses, pharmacists and the DIPC."
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "The audits as a minimum follow the PHE recommended principle of prescribing \u2018Start smart-then Focus' (updated 2015) (see appendices 1 and 2)."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "The Antimicrobial Stewardship Group and the DIPC will review antibiotic consumption trends regularly (at least annually)."
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Action will be taken by the Antimicrobial Stewardship Group to investigate any non- adherence to local protocols for antibiotic prescribing (based on best practice) or unexpected trends in prescribing. These must be documented in group minutes and any reports."
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "The DIPC must consider formal investigation of cases of repeated non-compliance (without clinical justification) or inappropriate prescribing, particularly when these result in an adverse patient outcome (e.g. development of an HCAI, prolonged length of stay, etc.). Any decisions not to investigate must be documented by the Antimicrobial Stewardship Group."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "It is important that audits include impact on patient outcome to ensure that qualitative or quantitative alterations (changing, reducing, restricting) to"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "text": "antimicrobial prescribing do not have unintended detrimental effects for example increased time to clinical cure, increased mortality, increased readmission rate."
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Education & Training"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Antimicrobial prescribers, pharmacists and nurses must receive (or as a minimum complete the online training in 8.2 below) information covering relevant aspects of antimicrobial prescribing, dispensing, administration and counselling on induction. It must cover the existing antimicrobial guidelines and formulary."
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "All clinical staff involved in antimicrobial use and supply must be competent on AMS and AMR expectations, online resources are available within the online Trust Learning Management System (formerly iLearn)."
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Nurses play a key role in the safe and timely administration of antibiotics and the collection of specimens that will enable a switch to targeted therapies should be recognised in each organisation. Nurses must be educated in the importance of maintaining therapeutic levels of prescribed medications, avoiding missed or delayed doses of antimicrobials and ensuring that all diagnostic tests are promptly carried out. Nurses also have a role to play in questioning and highlighting the duration of therapies and prescription of medications where these do not meet with established organisational guidelines."
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "type": "table",
            "sequence_num": 209,
            "data": {
                "num_rows": 4,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Duties of Committees and Individuals"
                    },
                    {
                        "text": "Audit (including review of minutes / reports)"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Quarterly"
                    },
                    {
                        "text": "Infection Prevention and Control Committee (IPCC), Grand round forum, Division/Directorates clinical governance meetings, Medicines Assurance group (MAG)"
                    },
                    {
                        "text": "MAG"
                    },
                    {
                        "text": "Antimicrobial guideline development"
                    },
                    {
                        "text": "Review guidelines"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "AMS, MAG"
                    },
                    {
                        "text": "MAG"
                    },
                    {
                        "text": "Formal investigations / Incident"
                    },
                    {
                        "text": "Review Antimicrobi al Group / MOSG"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "Site MOSG"
                    },
                    {
                        "text": "MAG"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 210,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "reporting"
                    },
                    {
                        "text": "minutes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Audit programme (in line with section 7 & appendices 1 and 2) Audit no of patients that received counselling on antibiotics prior to discharge"
                    },
                    {
                        "text": "Review reports"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "Site MOSG"
                    },
                    {
                        "text": "MAG"
                    },
                    {
                        "text": "Education & Training"
                    },
                    {
                        "text": "Review Induction programme Review online Training programme & uptake records"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "AMS Site MOSG"
                    },
                    {
                        "text": "MAG"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All policies, procedures and guidelines will be approved by Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "It is the author's responsibility to inform all prescribers, nursing and pharmacy of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 3)"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2007). Antimicrobial Prescribing \u2013 A summary of best practice."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2015). Antimicrobial Stewardship: Start Smart then Focus."
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "University Hospital of South Manchester NHS Foundation Trust (2010). Acute Hospital Antimicrobial Self-Assessment Tool Accessed 26/02/21 at http://www.researchdirectorate.org.uk/uhsm/asat/file/Antimicrobial%20Self%20Asse ssment%20Toolkit%20-%20609725462A194E1124202.xls."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health and Social Care (2019) UK Five Year Antimicrobial Resistance Strategy."
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Institute of Clinical Excellence (NICE 2015). Antimicrobial Stewardship Guidelines and Baseline assessment tool."
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England (2015). Patient Safety Alert - NHS/PSA/Re/2015/007: Addressing antimicrobial resistance through implementation of an antimicrobial stewardship programme."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NICE guideline (NG15) August 2015. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use."
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the Management of Antimicrobials/ MSEPO-21054/1.0"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1 - Components of Best Practice for Antibiotic Prescribing (Treatment)"
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "type": "image",
            "sequence_num": 227,
            "data": {
                "url": "MSEPO-21054 MSE Policy for Management of Antimicrobials 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 228,
            "data": {
                "num_rows": 6,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Audit Measure"
                    },
                    {
                        "text": "Detail"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Frequency"
                    },
                    {
                        "text": "Urgent treatment of infection emergencies"
                    },
                    {
                        "text": "For severe or life-threatening infection, start prompt treatment with broad-spectrum antibiotic agents urgently (within one hour of diagnosis)."
                    },
                    {
                        "text": "Delay to starting adequate antibiotic therapy in severe infection is associated with increased morbidity and mortality"
                    },
                    {
                        "text": "Annual audit Time to 1st dose from onset of severe sepsis."
                    },
                    {
                        "text": "Communication of decision to prescribe antibiotics"
                    },
                    {
                        "text": "Document the decision to start antibiotic therapy along with the indication or provisional diagnosis in medical records and on medication charts (must include clear identification of prescriber and contact details)"
                    },
                    {
                        "text": "Communication between healthcare teams is vital to safe and effective patient care and mandated by the Royal Colleges. Requirement to document prescribing will discourage antibiotic prescribing where evidence of infection is lacking."
                    },
                    {
                        "text": "Annual Audit of documentation of indication in medical records (Chart and notes) and duration / review on prescriptions"
                    },
                    {
                        "text": "Microbiology culture and sensitivities (M C&S)"
                    },
                    {
                        "text": "Appropriate specimens should be obtained for MC&S according to local guidelines."
                    },
                    {
                        "text": "Allows for prompt de- escalation of broad-spectrum agents or tailoring therapy in cases of treatment failure."
                    },
                    {
                        "text": "Audit annually for specific infections."
                    },
                    {
                        "text": "Documenting Antimicrobial Decision Making"
                    },
                    {
                        "text": "Daily review must include documentation in the notes of the decision from the 5 choices: Stop, Switch IV to Oral, Change, Continue or OPAT"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Annual Audit of notes"
                    },
                    {
                        "text": "De-escalation"
                    },
                    {
                        "text": "Review of MC&S results should be documented within 24 hours of reporting and broad-spectrum therapy de-escalated or a rationale documented for continuing."
                    },
                    {
                        "text": "Unnecessary continuation of broad-spectrum antibiotics is associated with healthcare- associated infection"
                    },
                    {
                        "text": "Annual de-escalation audit OR Monitoring consumption of broad spectrum agents."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "type": "table",
            "sequence_num": 230,
            "data": {
                "num_rows": 6,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Audit Measure"
                    },
                    {
                        "text": "Detail"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Frequency"
                    },
                    {
                        "text": "Guideline choice of agent(s)"
                    },
                    {
                        "text": "Select antibiotic therapy according to local guidelines where available. Document rationale for deviation from local guidelines."
                    },
                    {
                        "text": "Communication mandated by Royal Colleges. Will discourage off-guideline prescribing whilst allowing for exceptional cases. May opt to include dose and route of administration in audit."
                    },
                    {
                        "text": "Annual audit Audit adherence of agent, dose or rational alternative against guidelines"
                    },
                    {
                        "text": "Review date"
                    },
                    {
                        "text": "An expected duration or review date should be documented on the prescription when antibiotics are prescribed."
                    },
                    {
                        "text": "Communication mandated by Royal Colleges. Will discourage open-ended prescriptions."
                    },
                    {
                        "text": "Annual audit Audit of documentation of indication in medical records (Chart and/or notes) and duration / review on prescriptions"
                    },
                    {
                        "text": "IV duration"
                    },
                    {
                        "text": "Treatment with IV antibiotics should not continue beyond 48-72 hours unless recommended by local guideline or microbiologist. Rationale for continuing IV should be clearly documented."
                    },
                    {
                        "text": "Unnecessary continuation of IV treatment increases the risk of line infection."
                    },
                    {
                        "text": "Annual audit Monitor consumption of IV antibiotics vs oral Detailed audit of IV antibiotics prescribed for longer than 48 hours"
                    },
                    {
                        "text": "IV-to-oral switch"
                    },
                    {
                        "text": "Treatment with IV antibiotics should be switched to oral therapy within 24 hours of meeting local switch criteria."
                    },
                    {
                        "text": "Unnecessary continuation of IV treatment increases the risk of line infection."
                    },
                    {
                        "text": "Annual audit (IV-to-oral switch) OR Monitoring consumption of IV vs oral antibiotics"
                    },
                    {
                        "text": "Total duration"
                    },
                    {
                        "text": "Treatment with antibiotics should not continue beyond 7 days (IV and oral) unless recommended by a local guideline or microbiologist. Rationale for continuing should be clearly documented."
                    },
                    {
                        "text": "Prolonged treatment with antibiotics for uncomplicated infection is not associated with improved outcome."
                    },
                    {
                        "text": "Annual audit Monitor total consumption of antibiotics"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2 - Components of Best Practice for Antibiotic Prescribing (Peri-operative prophylaxis)"
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "type": "table",
            "sequence_num": 232,
            "data": {
                "num_rows": 5,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Audit Measure"
                    },
                    {
                        "text": "Detail"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Frequency"
                    },
                    {
                        "text": "Need for prophylaxis"
                    },
                    {
                        "text": "Indication should comply with NICE NG125: Prevention and treatment of surgical site infection or other evidence based recommendations i.e. prophylaxis \u2018recommended' or \u2018should be considered' for a procedure. Antibiotic prophylaxis is usually only recommended for clean-contaminated, contaminated or dirty procedures, in accordance with local guidelines."
                    },
                    {
                        "text": "For certain clean procedures, evidence suggests a lack of benefit of antibiotics. However, prophylaxis is required for clean surgery involving the placement of a prosthesis or implant"
                    },
                    {
                        "text": "Annual audit of local surgical prophylaxis practice"
                    },
                    {
                        "text": "Guideline choice of agents"
                    },
                    {
                        "text": "Prescribe prophylaxis with appropriate agents according to local guidelines. Use narrow spectrum agent(s) when possible. Avoid cephalosporins, clindamycin, and quinolones whenever possible. Use appropriate alternatives for patients with penicillin/ beta-lactam allergy"
                    },
                    {
                        "text": "Ensure adequate coverage of expected pathogens according to surgical site."
                    },
                    {
                        "text": "Annual audit of local surgical prophylaxis practice"
                    },
                    {
                        "text": "Timing"
                    },
                    {
                        "text": "Administer antibiotics within 60-minutes prior to incision (or tourniquet) or according to local guidelines"
                    },
                    {
                        "text": "Lowest surgical site infection rates associated with pre-incision administration."
                    },
                    {
                        "text": "Annual audit of local surgical prophylaxis practice"
                    },
                    {
                        "text": "Duration/Repeat doses"
                    },
                    {
                        "text": "Single dose is indicated for majority of procedures. Reason for antibiotic administration beyond one dose should be documented, and comply with criteria below:"
                    },
                    {
                        "text": "Antibiotics often short half-life or haemodilution effect with replacement fluid or blood products."
                    },
                    {
                        "text": "Annual audit of local surgical prophylaxis practice"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 233,
            "data": {
                "num_rows": 3,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Audit Measure"
                    },
                    {
                        "text": "Detail"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Frequency"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Significant intra-operative blood loss - >1.5 litre (re-dose following fluid replacement). Prolonged procedures (> 6 hours) or where there is significant blood loss may require an additional dose of prophylactic antibiotic \u2013 organisations should develop local recommendations for individual patients/procedures , taking into consideration a repeat dose of antibiotic prophylaxis when the operation is longer than the half-life of the antibiotic given. Primary arthroplasty (Single dose is preferable but up to 24 hours prophylaxis acceptable). For certain procedures up to 24 hours of prophylaxis may be warranted and for open heart surgery up to 48 hours"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "MRSA positive patients"
                    },
                    {
                        "text": "Decolonisation therapy is recommended prior to surgery and antibiotic prophylaxis should include cover for MRSA. Glycopeptides or co- trimoxazole are suitable agents. Gentamicin may also be considered if local resistance rates are low"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Integrate into current Saving Lives audits* for surgery or MRSA decolonisation audits"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix3: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Policy for Management of Antimicrobials: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "type": "table",
            "sequence_num": 236,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 237,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonisation into MSE-wide document"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Harmonisation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Consistent policy in all areas of Trust"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "Nil \u2013 standard national implementation of antimicrobial management"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 238,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Principal Antimicrobial Pharmacist"
                    },
                    {
                        "text": "22 March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the Management of Antimicrobials/ MSEPO-21054/1.0"
            },
            "type": "ListItem",
            "sequence_num": 240
        }
    ]
}